DENVER — Clinicians and researchers at National Jewish Health studied COVID vaccine effectiveness in patients with underlying lung conditions such as asthma, chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Findings show that nearly half of respiratory patients have lower vaccine-specific antibody, B cell, and T cell responses…Read More
Research Probes COVID Vaccine Efficacy in Lung Patients
